This company has been marked as potentially delisted and may not be actively trading. Vaccitech (VACC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesInsider TradesTrendsBuy This Stock VACC vs. PROC, OPTN, VIRI, WHWK, VHAQ, PYRGF, OSTX, AADI, NBRV, and ATNMShould you be buying Vaccitech stock or one of its competitors? The main competitors of Vaccitech include Procaps Group (PROC), OptiNose (OPTN), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), Viveon Health Acquisition (VHAQ), PyroGenesis Canada (PYRGF), OS Therapies (OSTX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), and Actinium Pharmaceuticals (ATNM). Vaccitech vs. Its Competitors Procaps Group OptiNose Virios Therapeutics Whitehawk Therapeutics Viveon Health Acquisition PyroGenesis Canada OS Therapies Aadi Bioscience Nabriva Therapeutics Actinium Pharmaceuticals Vaccitech (NASDAQ:VACC) and Procaps Group (NASDAQ:PROC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk. Which has more risk and volatility, VACC or PROC? Vaccitech has a beta of -0.4, meaning that its share price is 140% less volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.05, meaning that its share price is 105% less volatile than the S&P 500. Does the media refer more to VACC or PROC? In the previous week, Vaccitech's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score. Company Overall Sentiment Vaccitech Neutral Procaps Group Neutral Which has better valuation & earnings, VACC or PROC? Procaps Group has higher revenue and earnings than Vaccitech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccitech$13.42M2.83$5.34M-$1.43-0.69Procaps Group$409.92M0.26$42.54MN/AN/A Do institutionals & insiders hold more shares of VACC or PROC? 26.1% of Vaccitech shares are held by institutional investors. 6.0% of Vaccitech shares are held by insiders. Comparatively, 19.9% of Procaps Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is VACC or PROC more profitable? Procaps Group has a net margin of 0.00% compared to Vaccitech's net margin of -409.18%. Procaps Group's return on equity of 0.00% beat Vaccitech's return on equity.Company Net Margins Return on Equity Return on Assets Vaccitech-409.18% -23.41% -20.85% Procaps Group N/A N/A N/A SummaryProcaps Group beats Vaccitech on 7 of the 9 factors compared between the two stocks. Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VACC vs. The Competition Export to ExcelMetricVaccitechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.97M$790.52M$5.54B$8.99BDividend YieldN/A4.84%5.25%4.04%P/E Ratio-0.691.3027.5520.17Price / Sales2.83225.41432.66125.29Price / Cash19.3023.4436.8257.86Price / Book0.156.138.105.60Net Income$5.34M-$27.58M$3.17B$248.58M Vaccitech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VACCVaccitechN/A$0.99+6.2%N/A-34.0%$37.97M$13.42M-0.6933PROCProcaps GroupN/A$0.95-40.3%N/A-62.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeOPTNOptiNose0.7301 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190VIRIVirios TherapeuticsN/A$4.95+3.8%$5.00+1.0%+1,782.4%$95.33MN/A-18.335Gap UpWHWKWhitehawk TherapeuticsN/A$1.88+1.1%N/AN/A$88.57M$25.98M11.7540VHAQViveon Health AcquisitionN/A$11.00flatN/A+10.0%$62.26MN/A0.002High Trading VolumePYRGFPyroGenesis Canada0.1033 of 5 stars$0.33flatN/A-43.0%$62.17M$9.14M-5.5590News CoverageGap DownOSTXOS Therapies2.7842 of 5 stars$1.91-1.0%$18.00+842.4%N/A$53.67MN/A-2.22N/AAADIAadi Bioscience0.645 of 5 stars$1.86-0.5%$1.67-10.4%+44.5%$45.94M$25.07M-0.8240NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ATNMActinium Pharmaceuticals2.9553 of 5 stars$1.43+5.9%$4.00+179.7%N/A$44.61M$81K-1.0330 Related Companies and Tools Related Companies Procaps Group Competitors OptiNose Competitors Virios Therapeutics Competitors Whitehawk Therapeutics Competitors Viveon Health Acquisition Competitors PyroGenesis Canada Competitors OS Therapies Competitors Aadi Bioscience Competitors Nabriva Therapeutics Competitors Actinium Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VACC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VACC Stock Alerts